Rare sugar d-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells

Nutrition Research

Volumn 32, Issue 2, 2012, Pages 116-123

  Yamada, Kana ^a   Noguchi, Chisato ^a   Kamitori, Kazuyo ^a   Dong, Youyi ^a   Hirata, Yuko ^a   Hossain, Mohammad A ^a   Tsukamoto, Ikuko ^b   Tokuda, Masaaki ^a   Yamaguchi, Fuminori ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

D allose; Osteoclast; RAW264 cells; Thioredoxin 1; TXNIP

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALLOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; OSTEOCLAST DIFFERENTIATION FACTOR; THIOREDOXIN 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ASSAY; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; THIOREDOXIN INTERACTING PROTEIN GENE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GLUCOSE; MICE; OSTEOCLASTS; OXIDATIVE STRESS; PLASMIDS; RANK LIGAND; STAINING AND LABELING; THIOREDOXINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84857136973     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.12.010     Document Type: Article

References (28)

1. Sakiyama H., Masuda R., Inoue N., Yamamoto K., Kuriiwa K., Nakagawa K., et al. Establishment and characterization of macrophage-like cell lines expressing osteoclast-specific markers. J Bone Miner. Metab 2001, 19:220-227.
2. Takahashi N., Udagawa N., Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 1999, 256:449-455.
3. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
4. Paolicchi A., Dominici S., Pieri L., Maellaro E., Pompella A. Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 2002, 64:1027-1035.
5. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
6. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., Partington G.A., et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003, 112:915-923.
7. Holmgren A. Thioredoxin. Annu Rev Biochem 1985, 54:237-271.
8. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999, 31:273-300.
9. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 1997, 11:3482-3496.
10. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 1999, 274:27891-27897.
11. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994, 266:443-448.
12. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3:889-901.
13. Lean J., Kirstein B., Urry Z., Chambers T., Fuller K. Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species. Biochem Biophys Res Commun 2004, 321:845-850.
14. Izumori K. Bioproduction strategies for rare hexose sugars. Naturwissenschaften 2002, 89:120-124.
15. Sui L., Dong Y., Watanabe Y., Yamaguchi F., Hatano N., Tsukamoto I., et al. The inhibitory effect and possible mechanisms of d-allose on cancer cell proliferation. Int J Oncol 2005, 27:907-912.
16. Yamaguchi F., Takata M., Kamitori K., Nonaka M., Dong Y., Sui L., et al. Rare sugar d-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1. Int J Oncol 2008, 32:377-385.
17. Chen K.S., DeLuca H.F. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1994, 1219:26-32.
18. Watanabe R., Nakamura H., Masutani H., Yodoi J. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther 2010, 127:261-270.
19. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999, 274:21645-21650.
20. Wittrant Y., Gorin Y., Woodruff K., Horn D., Abboud H.E., Mohan S., et al. High d(+) glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 2008, 42:1122-1130.
21. Suna S., Yamaguchi F., Kimura S., Tokuda M., Jitsunari F. Preventive effect of d-psicose, one of rare ketohexoses, on di-(2-ethylhexyl) phthalate (DEHP)-induced testicular injury in rat. Toxicol Lett 2007, 173:107-117.
22. Murata A., Sekiya K., Watanabe Y., Yamaguchi F., Hatano N., Izumori K., et al. A novel inhibitory effect of d-allose on production of reactive oxygen species from neutrophils. J Biosci Bioeng 2003, 96:89-91.
23. Aitken C.J., Hodge J.M., Nishinaka Y., Vaughan T., Yodoi J., Day C.J., et al. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling. J Bone Miner Res 2004, 19:2057-2064.
24. Gómez del Arco P., Martínez-Martínez S., Calvo V., Armesilla A.L., Redondo J.M. JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes. J Biol Chem 1996, 271:26335-26340.
25. Meyer M., Schreck R., Baeuerle P.A. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993, 12:2005-2015.
26. Rao A.K., Ziegler Y.S., McLeod I.X., Yates J.R., Nardulli A.M. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. J Mol Endocrinol 2009, 43:6288-6293.
27. Kennel K.A., Drake M.T. Adverse effects of bisphosphonates: implications for Osteoporosis Management. Mayo Clin Proc 2009, 84:632-638.
28. Iga Y., Nakamichi K., Shirai Y., Matsuo T. Acute and sub-chronic toxicity of d-allose in rats. Biosci Biotechnol Biochem 2010, 74:1476-1478.